EMEA Meningitis Diagnostic Testing Market

1. Europe and Middle East & Africa Meningitis Diagnostic Testing Market Outlook 2031 The EMEA meningitis diagnostic testing market was valued over US$ 55.95 Mn in 2020 It is estimated to expand at a CAGR of 3.7% from 2021 to 2031 The EMEA meningitis diagnostic testing market isexpected to reach the value of US$ 83.51 Mn by the end of 2031 Report meningitis-diagnostic-testing-market.html Overview: https://www.transparencymarketresearch.com/emea- New Kits Hold Potentials to Improve Molecular Diagnosis of Bacterial Meningitis The technology of diagnostic kit for bacterial meningitis using real-time HRM PCR holds potential to improve clinical numbers. Companies in the EMEA meningitis diagnostic testing market should collaborate with researchers to develop new kits that help to cut down costs of molecular diagnosis of bacterial meningitis. Stakeholders are taking efforts to increase the availability of these kits amongst the common public and mainly at private laboratories. Companies in the EMEA meningitis diagnostic testing market are increasing R&D in developing kits that make use of a single fluorophore to detect the target genes through melting temperature analysis of the bacterial target gene. It has been found that each gene detected has a different melting temperature, easily visualized in a graph at the end of the amplification. Early Diagnosis of COVID-19 and Meningitis to Prevent Disease Spread Common symptoms of COVID-19 and meningitis are creating concerns for both healthcare providers and the general public. Thus, robust diagnostic testing has become the need of the hour during the ongoing pandemic. Stakeholders in the EMEA meningitis diagnostic testing market are increasing the availability of products to meet healthcare needs of individuals. In order to reduce stress on healthcare facilities, stakeholders in the EMEA meningitis diagnostic testing market are increasing awareness and facilitating early diagnosis to prevent the spread of diseases. They are maintaining optimum inventory levels to ensure continuity in supply chains. Companies are rethinking their manufacturing activities since financial situations have been squeezed for many. They are taking data-driven decisions to sustain volatile market sentiments. Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84 238

2. Logistical Challenges in Africa Affect Clinical Numbers for Meningitis Diagnostic Testing Transporting samples to laboratories have many logistical challenges in countries falling under the meningitis belt in Africa, as latex agglutination requires refrigeration and lab equipment. Moreover, this technique is dependent on a sample of spinal fluid from the patient taken by lumber puncture. Participants in the market should collaborate with clinicians, medical practitioners, and labs to invest in training of medical staff or hire trained staff in primary healthcare settings and remote areas. Molecular Diagnostic Assays Help Distinguish Between Different Bacteria Bacterial meningitis is becoming one of the major causes of morbidity and mortality. Participants in the EMEA meningitis diagnostic testing market are taking advantage of this opportunity to enable rapid identification of the aetiological agent of meningitis. Such innovations are benefitting healthcare providers participating in clinical and public health management. Since microbiological culture is complex, slow, and often impacted by prior antimicrobial treatment of the patient, companies in the EMEA meningitis diagnostic testing market are increasing the availability of molecular diagnostic assays for bacterial detection. Distinguishing between meningitis caused by meningococcus, pneumococcus, and others is becoming an important aspect of detection techniques. PCR Tests Support Rapid Outbreak Detection in Africa Rapid diagnostic tests are significantly changing the EMEA meningitis diagnostic testing market. Companies are offering new lateral flow tests for the diagnosis of Neisseria meningitides, MeningoSpeed, and other bacteria to support rapid outbreak detection in Africa. The microbial diagnosis of meningitis is currently based on culture or more frequently on polymerase chain reaction (PCR) tests carried out by national reference laboratories (NRLs) on a sample of cerebrospinal fluid (CSF). PCR tests require the maintaining of sample in a cold chain in primary health care centers (PHCs) and during transportation to the NRL. However, this makes the early identification of circulating strains difficult. In order to reduce the time needed to detect circulating strains, healthcare companies are developing diagnostic tests that can be used at bedside. Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market: Overview Meningitis is an infection of the protective membranes that surround the brain and spinal cord. It can affect anyone, but is most common in babies, young children, teenagers, and young adults. Symptoms include fever, headache, stiff neck, seizures, and others. The various types of meningitis are viral meningitis, bacterial meningitis, and fungal meningitis.

3. Latex agglutination test is a passive agglutination test, wherein analytes (antigens) are adsorbed onto latex particles. The test has a range of specificity and sensitivity, ranging from 60% to 93% for various microorganisms (such as Streptococcus pneumonia, Hemophilus influenzae, and Neisseria meningitidis). Lateral flow assay is also known as immunochromatographic test or dipstick assay. It is a paper-based test to detect analytes (antigens) in a complex mixture, wherein the sample to be analyzed is placed on a device and results are displayed within five to 30 minutes. These tests are widely used as point- of-care testing. Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market: Key Drivers Rise in demand for point-of-care services is anticipated to drive the meningitis diagnostic testing market in EMEA during the forecast period. Point-of-care services provide more accurate results in less time compared to traditional methods. New, innovative technologies such PCR and next-generation sequencing are available in the market, providing a less expensive way for the diagnosis, prognosis, and therapy selection in patients during their treatment. This helps physicians frame appropriate therapeutic systems for patients suffering from the infectious disease. In May 2018, BioGX B.V. launched Six CE-Mark tests for meningitis and antibiotic resistance. Meningitis test includes viral meningitis HSV/VZV, bacterial meningitis NSH, and bacterial meningitis ELGBS. Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&re p_id=84238 Market Segmentation: Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market In terms of product type, the meningitis diagnostic testing market in EMEA has been classified into latex agglutination tests, lateral flow assay, PCR assay, ELISA tests, culture test, and others Based on panel type, the meningitis diagnostic testing market in EMEA has been bifurcated into syndromic full multiplex panel and low plex panel In terms of end-user, the meningitis diagnostic testing market in EMEA has been divided into hospitals, diagnostic laboratories, and others Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The meningitis diagnostic testing market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate

4. (percentage CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations. Regional Overview: Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market Europe dominated the meningitis diagnostic testing market in EMEA in 2020, accounting for 87.9% share. Increase in health awareness, rise in expenditure on healthcare infrastructure, and surge in demand for better healthcare facilities fuel the growth of the market in Europe. Germany is projected to be an attractive market from 2021 to 2031. The country is anticipated to account for significant share of the market in Europe during the forecast period. Growth of the market in Germany can be attributed to increase in research activities, rise in government funding for research & development, and surge in the number of biotechnology companies. Major Players The meningitis diagnostic testing market report concludes with the company profiles section, which includes key information about major players in the meningitis diagnostic testing market in EMEA Leading players analyzed in the report include oThermo Fisher Scientific, Inc. oAbbott Laboratories oBioFire Diagnostics oBio-Rad Laboratories, Inc. oELITechGroup oFast Track Diagnostics Ltd. (Siemens Healthineers) oIMMY oNanosphere (Luminex Corporation) oQnostics oSeegene, Inc. Each of these players has been profiled in the meningitis diagnostic testing market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments About Transparency Market Research Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End-Use that will favor growth in the market over the next 9 years.

5. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ Contact Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email:sales@transparencymarketresearch.com